Shares Outstanding Shares Outstanding n/a Close	8.08M
Shares Change (YoY) Shares Change (YoY) n/a Close	-0.28%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0.25%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	12.79%
Shares Floating Shares Floating n/a Close	4.43M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	2,399
FTD / Avg. Volume FTD / Avg. Volume n/a Close	20.27%

Short Selling Information

The latest short interest is 9.37K, so 0.12% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	9.37K
Short % of Shares Out Short % of Shares Out n/a Close	0.12%
Short % of Float Short % of Float n/a Close	0.18%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1

Valuation Ratios

The PE ratio is 175.31 and the forward PE ratio is -135.5. Cryo-Cell International's PEG ratio is -1.68.

PE Ratio PE Ratio n/a Close	175.31
Forward PE Forward PE n/a Close	-135.5
PS Ratio PS Ratio n/a Close	2.2
Forward PS Forward PS n/a Close	1.3
PB Ratio PB Ratio n/a Close	-5.33
P/FCF Ratio P/FCF Ratio n/a Close	19.54
PEG Ratio PEG Ratio n/a Close	-1.68

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cryo-Cell International.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 0.58, with a Debt / Equity ratio of -0.98.

Current Ratio Current Ratio n/a Close	0.58
Quick Ratio Quick Ratio n/a Close	0.55
Debt / Equity Debt / Equity n/a Close	-0.98
Debt / EBITDA Debt / EBITDA n/a Close	9.09
Debt / FCF Debt / FCF n/a Close	3.59
Interest Coverage Interest Coverage n/a Close	1.87

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$390,074.46
Profits Per Employee Profits Per Employee n/a Close	$4,903.6
Employee Count Employee Count n/a Close	82
Asset Turnover Asset Turnover n/a Close	0.49
Inventory Turnover Inventory Turnover n/a Close	12.08

Taxes

Income Tax Income Tax n/a Close	2.4M
Effective Tax Rate Effective Tax Rate n/a Close	85.66%

Stock Price Statistics

The stock price has increased by -35.99% in the last 52 weeks. The beta is 0.74, so Cryo-Cell International's price volatility has been higher than the market average.

Beta Beta n/a Close	0.74
52-Week Price Change 52-Week Price Change n/a Close	-35.99%
50-Day Moving Average 50-Day Moving Average n/a Close	5.28
200-Day Moving Average 200-Day Moving Average n/a Close	6.75
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	50.15
Average Volume (20 Days) Average Volume (20 Days) n/a Close	11,836

Income Statement

In the last 12 months, Cryo-Cell International had revenue of 31.99M and earned 402.1K in profits. Earnings per share was 0.05.

Revenue Revenue n/a Close	31.99M
Gross Profit Gross Profit n/a Close	24.04M
Operating Income Operating Income n/a Close	3.48M
Net Income Net Income n/a Close	402.1K
EBITDA EBITDA n/a Close	1.42M
EBIT EBIT n/a Close	939.44K
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	0.05

Full Income Statement

Balance Sheet

The company has 560.96K in cash and 12.93M in debt, giving a net cash position of -12.37M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	560.96K
Total Debt Total Debt n/a Close	12.93M
Net Cash Net Cash n/a Close	-12.37M
Retained Earnings Retained Earnings n/a Close	-32.78M
Total Assets Total Assets n/a Close	64.38M
Working Capital Working Capital n/a Close	-9.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.01M and capital expenditures -2.4M, giving a free cash flow of 3.61M.

Operating Cash Flow Operating Cash Flow n/a Close	6.01M
Capital Expenditures Capital Expenditures n/a Close	-2.4M
Free Cash Flow Free Cash Flow n/a Close	3.61M
FCF Per Share FCF Per Share n/a Close	0.44

Full Cash Flow Statement

Margins

Gross margin is 75.15%, with operating and profit margins of 10.88% and 1.26%.

Gross Margin Gross Margin n/a Close	75.15%
Operating Margin Operating Margin n/a Close	10.88%
Pretax Margin Pretax Margin n/a Close	8.77%
Profit Margin Profit Margin n/a Close	1.26%
EBITDA Margin EBITDA Margin n/a Close	4.45%
EBIT Margin EBIT Margin n/a Close	10.88%
FCF Margin FCF Margin n/a Close	11.28%

Dividends & Yields

CCEL does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for CCEL is $8.5, which is 62.5% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$8.5
Price Target Difference Price Target Difference n/a Close	62.5%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$0.25
Lynch Upside Lynch Upside n/a Close	-95.22%
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Scores

Altman Z-Score Altman Z-Score n/a Close	0.02
Piotroski F-Score Piotroski F-Score n/a Close	9